NZ722213A - Method for generating high-titer hepatitis e virus stocks and titration assay for hepatitis e virus - Google Patents
Method for generating high-titer hepatitis e virus stocks and titration assay for hepatitis e virusInfo
- Publication number
- NZ722213A NZ722213A NZ722213A NZ72221316A NZ722213A NZ 722213 A NZ722213 A NZ 722213A NZ 722213 A NZ722213 A NZ 722213A NZ 72221316 A NZ72221316 A NZ 72221316A NZ 722213 A NZ722213 A NZ 722213A
- Authority
- NZ
- New Zealand
- Prior art keywords
- hepatitis
- virus
- titer
- generating high
- titration assay
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/05—Adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562195936P | 2015-07-23 | 2015-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ722213A true NZ722213A (en) | 2019-04-26 |
Family
ID=56409494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ722213A NZ722213A (en) | 2015-07-23 | 2016-07-15 | Method for generating high-titer hepatitis e virus stocks and titration assay for hepatitis e virus |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10208291B2 (enExample) |
| EP (1) | EP3121267B1 (enExample) |
| JP (1) | JP6588397B2 (enExample) |
| KR (1) | KR102154380B1 (enExample) |
| CN (1) | CN106367397B (enExample) |
| AR (1) | AR106015A1 (enExample) |
| AU (1) | AU2016204734B2 (enExample) |
| BR (1) | BR102016016677A2 (enExample) |
| CA (1) | CA2937088C (enExample) |
| CL (1) | CL2016001768A1 (enExample) |
| ES (1) | ES2669021T3 (enExample) |
| HU (1) | HUE036699T2 (enExample) |
| IL (1) | IL246634B (enExample) |
| MX (1) | MX375106B (enExample) |
| MY (1) | MY176204A (enExample) |
| NZ (1) | NZ722213A (enExample) |
| PL (1) | PL3121267T3 (enExample) |
| PT (1) | PT3121267T (enExample) |
| RU (1) | RU2691123C1 (enExample) |
| SG (1) | SG10201605867UA (enExample) |
| TW (1) | TWI666322B (enExample) |
| UY (1) | UY36778A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102158641B1 (ko) * | 2019-03-06 | 2020-09-22 | 대한민국 | 야누스 인산화효소 저해제 및 헥사디메트린 브로마이드를 포함하는 바이러스 배양용 조성물 및 이를 이용한 바이러스 배양 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6506604B2 (en) * | 1993-06-11 | 2003-01-14 | Cell Genesys, Inc. | Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| US6217858B1 (en) * | 1997-02-11 | 2001-04-17 | Hadasit & Medical Research Services & Development Company, Ltd. | Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| WO2003001198A1 (en) * | 2001-06-21 | 2003-01-03 | Regents Of The University Of California | Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| WO2007046962A2 (en) * | 2005-09-02 | 2007-04-26 | The University Of Maryland, Baltimore | Cell lines harboring hepatitis virus and methods for using thereof |
| JP2012504647A (ja) * | 2008-10-03 | 2012-02-23 | ザ ロックフェラー ユニヴァーシティ | 新規なｈｃｖ侵入因子、オクルディン |
| US9181530B2 (en) * | 2011-01-10 | 2015-11-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Infectious hepatitis E virus genotype 3 recombinants |
| US9789139B2 (en) * | 2011-06-10 | 2017-10-17 | Bluebird Bio, Inc. | Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
-
2016
- 2016-07-06 IL IL246634A patent/IL246634B/en active IP Right Grant
- 2016-07-07 UY UY0001036778A patent/UY36778A/es not_active Application Discontinuation
- 2016-07-08 AU AU2016204734A patent/AU2016204734B2/en active Active
- 2016-07-08 MX MX2016009048A patent/MX375106B/es active IP Right Grant
- 2016-07-08 RU RU2016127546A patent/RU2691123C1/ru active
- 2016-07-11 EP EP16178844.3A patent/EP3121267B1/en active Active
- 2016-07-11 HU HUE16178844A patent/HUE036699T2/hu unknown
- 2016-07-11 PL PL16178844T patent/PL3121267T3/pl unknown
- 2016-07-11 CL CL2016001768A patent/CL2016001768A1/es unknown
- 2016-07-11 PT PT161788443T patent/PT3121267T/pt unknown
- 2016-07-11 ES ES16178844.3T patent/ES2669021T3/es active Active
- 2016-07-12 MY MYPI2016702506A patent/MY176204A/en unknown
- 2016-07-15 NZ NZ722213A patent/NZ722213A/en not_active IP Right Cessation
- 2016-07-18 CN CN201610566601.8A patent/CN106367397B/zh active Active
- 2016-07-18 SG SG10201605867UA patent/SG10201605867UA/en unknown
- 2016-07-19 US US15/213,766 patent/US10208291B2/en active Active
- 2016-07-19 BR BR102016016677-2A patent/BR102016016677A2/pt not_active Application Discontinuation
- 2016-07-20 TW TW105122892A patent/TWI666322B/zh not_active IP Right Cessation
- 2016-07-21 AR ARP160102202A patent/AR106015A1/es not_active Application Discontinuation
- 2016-07-22 JP JP2016144065A patent/JP6588397B2/ja active Active
- 2016-07-22 CA CA2937088A patent/CA2937088C/en active Active
- 2016-07-22 KR KR1020160093629A patent/KR102154380B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AR106015A1 (es) | 2017-12-06 |
| CN106367397B (zh) | 2021-07-20 |
| HUE036699T2 (hu) | 2018-07-30 |
| EP3121267A1 (en) | 2017-01-25 |
| RU2691123C1 (ru) | 2019-06-11 |
| AU2016204734A1 (en) | 2017-02-09 |
| CA2937088C (en) | 2022-06-21 |
| EP3121267B1 (en) | 2018-03-28 |
| KR20170012140A (ko) | 2017-02-02 |
| ES2669021T3 (es) | 2018-05-23 |
| JP2017023143A (ja) | 2017-02-02 |
| CN106367397A (zh) | 2017-02-01 |
| KR102154380B1 (ko) | 2020-09-10 |
| PL3121267T3 (pl) | 2018-07-31 |
| CL2016001768A1 (es) | 2017-05-12 |
| IL246634B (en) | 2020-08-31 |
| MX375106B (es) | 2025-03-06 |
| BR102016016677A2 (pt) | 2019-02-12 |
| TWI666322B (zh) | 2019-07-21 |
| IL246634A0 (en) | 2016-12-29 |
| UY36778A (es) | 2016-09-30 |
| MX2016009048A (es) | 2017-01-23 |
| AU2016204734B2 (en) | 2019-11-21 |
| SG10201605867UA (en) | 2017-02-27 |
| CA2937088A1 (en) | 2017-01-23 |
| US10208291B2 (en) | 2019-02-19 |
| JP6588397B2 (ja) | 2019-10-09 |
| US20170022481A1 (en) | 2017-01-26 |
| PT3121267T (pt) | 2018-04-26 |
| MY176204A (en) | 2020-07-24 |
| TW201704468A (zh) | 2017-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124717T1 (el) | Μεθοδοι, kit και συσκευη για επεκταση πληθυσμου κυτταρων | |
| EA201992001A1 (ru) | Композиции и способы повышения экспрессии генов | |
| MX2016016902A (es) | Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas. | |
| WO2020123301A3 (en) | Generating spatial arrays with gradients | |
| CY1121217T1 (el) | Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων | |
| EA201991105A1 (ru) | Методы оценки риска с использованием общей и специфической неклеточной днк | |
| BR112017009728A2 (pt) | anticorpos isolados, ácido nucleico isolado, vetor, célula hospedeira, método para produzir o anticorpo, composição, usos de um anticorpo e métodos de tratamento de um distúrbio | |
| MX388517B (es) | Polipéptidos de transposasa y sus usos. | |
| EP4269577A3 (en) | Nucleobase editors and uses thereof | |
| GB2548740A (en) | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same | |
| MX2020009670A (es) | Metodos de cultivo por perfusion y usos de los mismos. | |
| PH12017501967A1 (en) | Maize plant dbn9936 and method for use in detecting nucleic acid sequence thereof | |
| AR093446A1 (es) | Anticuerpos de antihemaglutinina y metodos de uso | |
| MY181693A (en) | Dual quencher probes | |
| BR112017016897A2 (pt) | cepas fúngicas e métodos de uso | |
| MX2018015213A (es) | Secuencia de acido nucleico para detectar la existencia del evento de soya transgenica dbn9004 en una muestra biologica, equipo que contiene la misma y metodo de deteccion para la misma. | |
| GB2542576A (en) | Method and kit of detecting the absence of micro-oranisms | |
| MX2019011702A (es) | Ensayos de inmunogenicidad mejorados. | |
| AU2017248682A1 (en) | Method for detecting and/or characterising tumour cells and associated apparatus | |
| WO2014145870A3 (en) | Novel compositions, methods and kits for blood typing | |
| EP4282961A3 (en) | Compositions and methods for the detection and analysis of mycobacterium tuberculosis | |
| MX2016014359A (es) | Antigeno e de hepadnavirus marcado y su uso en el tamizado de sustancias antivirales. | |
| CA3077390A1 (en) | Methods and compositions for nucleic acid detection | |
| EA201791233A1 (ru) | Материал стволовых клеток и способ его получения | |
| MX2016017136A (es) | Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 JUL 2021 BY AJ PARK Effective date: 20200618 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 JUL 2022 BY AJ PARK Effective date: 20210623 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 JUL 2023 BY AJ PARK Effective date: 20220617 |
|
| LAPS | Patent lapsed |